In two separate studies, members of the American Thyroid Association (ATA), and the
European Thyroid Association (ETA) were surveyed by questionnaire on their management …

Members of the American Thyroid Association were invited to participate in a survey of the
management of Graves' disease. One primary case and several variations were provided …

The treatment of patients with Graves' disease involves a physician making a clinical
decision between one of the three modalities available for treatment, administering the …

In three separate studies, members of the American Thyroid Association (ATA), the
European Thyroid Association (ETA), and the Japan Thyroid Association (JTA) were …

In 1986, a survey on the management of hyperthyroidism due to Graves' disease was
undertaken in Europe. The survey was based on the results of a questionnaire mailed to all …

Background: The optimum therapy for Graves' disease (GD) is chosen following discussion
between physician and patient regarding benefits, drawbacks, potential side effects, and …

The large published literature on the management of Graves' Hyperthyroidism reflects the
persisting controversies regarding optimum management of this common condition. This …

Since no causative treatment of Graves' disease is available, symptomatic therapy has been
derived from clinical studies (evidence class I and II). To date, conservative treatment still …

Background: The treatment efficacy of antithyroid drug (ATD) therapy, radioactive iodine
(131I), or surgery for Graves' hyperthyroidism is well described. However, there are a few …

An opinion survey concerning the management of Graves' hyperthyroidism was conducted
among the council members of the Japan Thyroid Association. The selection of 3 major …